Echinacea Junior vs Vitamin C in Children 4-12 Years Old

• Status: Completed
• Trial end date: 2018-07-03
• Target enrollment: 0
• Participant gender: All

Summary

Aim of this study is to investigate efficacy and safety of Echinaforce Junior Tablets (250mg) in comparison with Vitamin C tablets in the prevention of acute viral respiratory tract infections.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: A. Vogel AG; Bioforce AG
• Treatments: Ascorbic Acid; Vitamins

Criteria

Inclusion Criteria:

• 4-12 years

• written informed consent by parents and optionally by child

• daily Access to computer/email

• german language skills

Exclusion Criteria:

• 13 years or older, younger than 4 years

• participation in a clinical study during past 30 days

• intake of antimicrobial, antiviral, immunosuppressive substances, salicylic medicaments (like Aspirin)

• surgical intervention 3 months Prior to inclusion or planned intervention during the observation period

• known Diabetes mellitus

• known and treated atopy or Asthma

• cystic fibrosis, bronchopulmonary dysplasia, chronic obstructive pulmonary disease (COPD)

• diseases of the immunosystem (like autoimmune disorders, degenerative illnesses (like AIDS or leucosis))

• Metabolic or Resorption disorders

• Liver or kidney diseases

• Serious health Problems (e.g. neurological Problems)

• known allergies against compositae (e.g. camomile or dandelion) or any of the substances of the investigational product